gentaur.com

Novel Reagent Using Spectrophotometry

Sensitive detection of iron (II) sulfate with a novel reagent using spectrophotometry

In this study, a novel reagent was developed for sensitive detection of iron (II) sulfate, spectrophotometrically. A novel thio-anthraquinone derivative, 1-(Dodecylthio)anthracene-9,10-dione (3), was synthesized from the chemical reaction of 1-Chloroanthraquinone (1) and 1-Dodecanethiol (2) by an original reaction method and was used in the preparation of the novel reagent called Catal’s reagent.
  • A synthesized thio-anthraquinone analogue (3) was purified by column chromatography, and its chemical structure was characterized by spectroscopic methods such as Fourier-transform infrared spectroscopy (FT-IR), nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and ultraviolet (UV)-visible spectrophotometry.
  • The chemical and molecular structure of the developed thio-antraquinone derivative (3) was illuminated using computational methods with the GaussView5 and Gaussian09 programs. Various solvents including ethanol, methanol, and acetonitrile were examined in the preparation of the reagent. A concentration range from 0.2 mg mL-1 up to 10 mg mL-1 of iron (II) sulfate heptahydrate solution in distilled water was prepared. The absorption spectra of Catal’s reagent (0.816 mM) showed three peaks between 185 nm-700 nm of wavelength.
  • However, after the reaction with H2O2 and the 30 mM trisodium citrate dihydrate mixture in the presence of an iron sulfate (II) solution, a single peak was observed, producing a stable and reddish/brownish homogenous solution (λ max = 304 nm).
  • The following concentrations of iron (II) sulfate heptahydrate was examined using developed protocol and the reagent, and the concentrations were measured spectrophotometrically at 304 nm, 0.2-1 mg mL-1. Absorbances of reaction mixtures of iron (II) sulfate remained stable up to 48 h.
  • The results indicated that the novel Catal’s reagent can be used for sensitive spectrophotometric detection of iron (II) sulfate in aqueous solutions.
gentaur.com

gentaur

CryoProtX Mix Reagents 1.5 mL

M-MDSR-61 1.5 ml ml
EUR 37
Description: CryoProtX Mix Reagents 1.5 mL

Set of 10 Biolipidure Reagents

Biolipidure-set 10mLx10
EUR 1820.4
Description: Set of 10 Biolipidure Reagents, whose applications include Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement

REAGENTS HIGH RANGE AMMONIA - PK25

HI73325 PK25
EUR 55.35

High Range Ammonia Reagents - EACH

HI9373301 EACH
EUR 130.95

Human CD34 ELISA Construction kit w/Developing Reagents & Plates

RHF661CKP - Ask for price

CryoProtX Mix Eco Reagents 1.5 mL

M-MDSR-61-ECO 1.5 ml ml
EUR 37
Description: CryoProtX Mix Eco Reagents 1.5 mL

PeliKine tool set, additional reagents

M1980 1 unit
EUR 169.8

Alkphos Direct Labelling Reagents - EACH

RPN3680 EACH
EUR 915.3

Macro & Micro-Test Sample Release Reagent

3005 1 Each Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8A 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8B 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8C 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8D 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8E 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8F 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8G 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8H 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8J 1 Kit Ask for price

Macro & Micro-Test Sample Release Reagent

HWTS-3005-8L 1 Kit Ask for price

Human VAP-1 w/Developing Reagents

RHF655CKC - Ask for price

BSA Standards for quantification reagents

BM0100 100000 Units in 2x 200 µL Ask for price

Human SCGF Alpha w/Developing Reagents

RHF664CKC - Ask for price

Macro & Micro-Test Sample Release Reagent (CRE)

3009 1 Each Ask for price

Free Chlorine Reagents 0-5mg/L - EACH

WAT1028 EACH
EUR 49.95

pH-sensitive IgG labeling reagents plus

UA070080
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 µg
  • 500 µg
  • 10 µg
  • 50 µg
  • 1 mg

Human TGF beta-3 w/Developing Reagents

RHF643CKC - Ask for price

iN-fect™ In vitro transfection reagents

15081 500 µL
EUR 127.27
Description: Transfection

Pre-Titrated Reagents for Human EGF ELISA

MBS590076-10Plates 10Plates
EUR 710

Pre-Titrated Reagents for Human EGF ELISA

MBS590076-5Plates 5Plates
EUR 520

Pre-Titrated Reagents for Human EGF ELISA

MBS590076-5x10Plates 5x10Plates
EUR 3270

Human VAP-1 w/Developing Reagents & Plates

RHF655CKP - Ask for price

Bradford(Coomassie) Protein Assay Plus Reagents

P7201-050 450ml
EUR 118

Bradford(Coomassie) Protein Assay Plus Reagents

P7201-100 950ml
EUR 130

Human Adiponectin ELISA w/Developing Reagents

RHF651CKC - Ask for price

Human Uteroglobin ELISA w/Developing Reagents

RHF656CKC - Ask for price

Human SCGF Alpha w/Developing Reagents & Plates

RHF664CKP - Ask for price

Rat EGF Construction Kit w/Developing Reagents

RRF312CKC - Ask for price

Rat SCF Construction Kit w/Developing Reagents

RRF432CKC - Ask for price

COMBI IC Reagent: Mouse anti CD45 (FITC) and Mouse anti CD14 (PE)

MBS570370-50Tests 50Tests
EUR 450

COMBI IC Reagent: Mouse anti CD45 (FITC) and Mouse anti CD14 (PE)

MBS570370-5x50Tests 5x50Tests
EUR 1885

Liposomal and Non-Liposomal Transfection Reagents

abx298032-100g 100 µg Ask for price

Liposomal and Non-Liposomal Transfection Reagents

abx298032-20g 20 µg
EUR 875

Liposomal and Non-Liposomal Transfection Reagents

abx298032-50g 50 µg Ask for price

Mouse KC Construction Kit w/Developing Reagents

RMF428CKC - Ask for price

Rat CNTF Construction Kit w/Developing Reagents

RRF426CKC - Ask for price

Pre-Titrated Reagents for Human IL-8 ELISA

MBS590074-10Plates 10Plates
EUR 710

Pre-Titrated Reagents for Human IL-8 ELISA

MBS590074-5Plates 5Plates
EUR 520

Pre-Titrated Reagents for Human IL-8 ELISA

MBS590074-5x10Plates 5x10Plates
EUR 3270

Human MIA Construction Kit w/Developing Reagents

RHF127CKC - Ask for price

Human GRO Construction Kit w/Developing Reagents

RHF250CKC - Ask for price

Human EGF Construction Kit w/Developing Reagents

RHF290CKC - Ask for price

Human MIG Construction Kit w/Developing Reagents

RHF450CKC - Ask for price

Human NOV Construction Kit w/Developing Reagents

RHF464CKC - Ask for price

Human SCF Construction Kit w/Developing Reagents

RHF540CKC - Ask for price

Human TPO Construction Kit w/Developing Reagents

RHF570CKC - Ask for price

Human LEC Construction Kit w/Developing Reagents

RHF690CKC - Ask for price

Human MDC Construction Kit w/Developing Reagents

RHF700CKC - Ask for price

Human MEC Construction Kit w/Developing Reagents

RHF785CKC - Ask for price

Human LIF Construction Kit w/Developing Reagents

RHF856CKC - Ask for price

Human OPG Construction Kit w/Developing Reagents

RHF907CKC - Ask for price

Mouse SCF Construction Kit w/Developing Reagents

RMF322CKC - Ask for price

Mouse MDC Construction Kit w/Developing Reagents

RMF363CKC - Ask for price

Mouse LIX Construction Kit w/Developing Reagents

RMF427CKC - Ask for price

Mouse EGF Construction Kit w/Developing Reagents

RMF437CKC - Ask for price

Rat VEGF Construcition Kit w/Developing Reagents

RRF501CKC - Ask for price

Pre-Titrated Reagents for Human MCP-1 ELISA

MBS590075-10Plates 10Plates
EUR 710

Pre-Titrated Reagents for Human MCP-1 ELISA

MBS590075-5Plates 5Plates
EUR 520

Pre-Titrated Reagents for Human MCP-1 ELISA

MBS590075-5x10Plates 5x10Plates
EUR 3270

Pre-Titrated Reagents for Human MCP-3 ELISA

MBS590077-10Plates 10Plates
EUR 710

Pre-Titrated Reagents for Human MCP-3 ELISA

MBS590077-5Plates 5Plates
EUR 520

Pre-Titrated Reagents for Human MCP-3 ELISA

MBS590077-5x10Plates 5x10Plates
EUR 3270

Pre-Titrated Reagents for Human IL-16 ELISA

MBS590080-10Plates 10Plates
EUR 710

Pre-Titrated Reagents for Human IL-16 ELISA

MBS590080-5Plates 5Plates
EUR 520

Pre-Titrated Reagents for Human IL-16 ELISA

MBS590080-5x10Plates 5x10Plates
EUR 3270

Pre-Titrated Reagents for Human IL-18 ELISA

MBS590083-10Plates 10Plates
EUR 710

Pre-Titrated Reagents for Human IL-18 ELISA

MBS590083-5Plates 5Plates
EUR 520

Pre-Titrated Reagents for Human IL-18 ELISA

MBS590083-5x10Plates 5x10Plates
EUR 3270

Human VEGF-B ELISA Kit w/Developing Reagents

RH644CKC - Ask for price

Human PD-L1 ELISA kits w/Developing Reagents

RHF642CKC - Ask for price

Human VEGF Construction Kit w/Developing Reagents

RH88820CKC - Ask for price

Human BRAK Construction Kit w/Developing Reagents

RHF123CKC - Ask for price

Human GDNF Construction Kit w/Developing Reagents

RHF240CKC - Ask for price

Human BDNF Construction Kit w/Developing Reagents

RHF270CKC - Ask for price

Human CTGF Construction Kit w/Developing Reagents

RHF461CKC - Ask for price

Human TSLP Construction Kit w/Developing Reagents

RHF466CKC - Ask for price

Human sDLL Construction Kit w/Developing Reagents

RHF505CKC - Ask for price

Human TARC Construction Kit w/Developing Reagents

RHF640CKC - Ask for price

Human TFF2 Construction Kit w/Developing Reagents

RHF652CKC - Ask for price

Human TECK Construction Kit w/Developing Reagents

RHF750CKC - Ask for price

 

Engineering caspase 7 as an affinity reagent to capture proteolytic products

Many proteases recognize their substrates with high specificities, with this in mind, it should theoretically be possible to utilize the substrate binding cleft of a protease as a scaffold to engineer an affinity reagent. In this study, we sought to develop reagents that would differentiate between substrates and products of proteolysis, based on a caspase 7 scaffold. Firstly, we engineered a form of caspase 7 that can undergo conversion to a substrate binding conformation without catalysis. Seeking to generate a product-only trap, we further engineered this construct by incorporating mutations that compensate for the generation of a negative charge in the neo C terminus of a newly generated product.
  • This was accomplished with only three substitutions within the substrate binding cleft. Moreover, the affinity of the product trap for peptides was comparable to the affinity of caspase 7 to parental substrates.
  • Finally, generation of a hybrid fluorescent protein with the product trap provided a reagent that specifically recognized apoptotic cells and highlights the versatility of such an approach in developing affinity and imaging agents for a variety of cysteine and serine proteases.

Leveraging nature’s biomolecular designs in next-generation protein sequencing reagent development

Next-generation approaches for protein sequencing are now emerging that could have the potential to revolutionize the field in proteomics. One such sequencing method involves fluorescence-based imaging of immobilized peptides in which the N-terminal amino acid of a polypeptide is readout sequentially by a series of fluorescently labeled biomolecules.

When selectively bound to a specific N-terminal amino acid, the NAAB (N-terminal amino acid binder) affinity reagent identifies the amino acid through its associated fluorescence tag. A key technical challenge in implementing this fluoro-sequencing approach is the need to develop NAAB affinity reagents with the high affinity and selectivity for specific N-terminal amino acids required for this biotechnology application.

One approach to develop such a NAAB affinity reagent is to leverage naturally occurring biomolecules that bind amino acids and/or peptides. Here, we describe several candidate biomolecules that could be considered for this purpose and discuss the potential for developability of each.

Key points • Next-generation sequencing methods are emerging that could revolutionize proteomics. • Sequential readout of N-terminal amino acids by fluorescent-tagged affinity reagents. • Native peptide/amino acid binders can be engineered into affinity reagents. • Protein size and structure contribute to feasibility of reagent developability.

3-Epikatonic acid

TN2931-50mg 50mg Ask for price
Description: 3-Epikatonic acid

3-Epikatonic acid

TN2931-5mg 5mg Ask for price
Description: 3-Epikatonic acid

3-Epikatonic acid

TB01910 5mg
EUR 1016.4

16-Epikoumidine

TN6036-10mg 10mg Ask for price
Description: 16-Epikoumidine

16-Epikoumidine

TN6036-1g 1g Ask for price
Description: 16-Epikoumidine

16-Epikoumidine

TN6036-1mg 1mg Ask for price
Description: 16-Epikoumidine

16-Epikoumidine

TN6036-50mg 50mg Ask for price
Description: 16-Epikoumidine

16-Epikoumidine

TN6036-5mg 5mg Ask for price
Description: 16-Epikoumidine

16-Epikoumidine

TTE1328 unit Ask for price

3-Epikarounidiol

TBZ1276 unit Ask for price

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34)

MBS6005618-02mL 0.2(mL
EUR 695

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34)

MBS6005618-5x02mL 5x0.2mL
EUR 2975

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (AP)

MBS6333596-02mL 0.2mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (AP)

MBS6333596-5x02mL 5x0.2mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (APC)

MBS6333597-02mL 0.2mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (APC)

MBS6333597-5x02mL 5x0.2mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (FITC)

MBS6333599-02mL 0.2mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (FITC)

MBS6333599-5x02mL 5x0.2mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (PE)

MBS6333606-02mL 0.2mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (PE)

MBS6333606-5x02mL 5x0.2mL
EUR 4250

Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358)

REC32058-100 0.1
EUR 280.67
Description: Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358)

Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358)

REC32058-500 0.5
EUR 1182.63
Description: Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358)

Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385)

REC32055-100 0.1
EUR 311.28
Description: Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385)

Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385)

REC32055-500 0.5
EUR 1182.63
Description: Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385)

Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898)

REC32056-100 0.1
EUR 311.28
Description: Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898)

Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898)

REC32056-500 0.5
EUR 1182.63
Description: Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898)

Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703)

REC32059-100 0.1
EUR 280.67
Description: Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703)

Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703)

REC32059-500 0.5
EUR 1182.63
Description: Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703)

Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366)

REC32057-100 0.1
EUR 280.67
Description: Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366)

Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366)

REC32057-500 0.5
EUR 1182.63
Description: Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366)

Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) hemagglutinin (EPI2076373)

REC32060-100 0.1
EUR 298.53
Description:
Influenza A/Greylag_goose/Scotland/024915/2022 hemagglutinin, C-terminally tagged with a T4 fooldon domain to stabilize trimer s.

Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) hemagglutinin (EPI2076373)

REC32060-500 0.5
EUR 1047.4
Description:
Influenza A/Greylag_goose/Scotland/024915/2022 hemagglutinin, C-terminally tagged with a T4 fooldon domain to stabilize trimer s.

Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372)

REC32061-100 0.1
EUR 298.53
Description:
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372), expressed in HEK293 cells and purified from culture supernatant. The protein is stabilized as a tetramer via an N-terminal tetrabrachion domain

Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372)

REC32061-500 0.5
EUR 1047.4
Description:
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372), expressed in HEK293 cells and purified from culture supernatant. The protein is stabilized as a tetramer via an N-terminal tetrabrachion domain

EPI-7170

HY-150102 10 mg
EUR 1590.93
Description: EPI-7170, a ralaniten analogue, is a potent androgen receptor N-terminal structural domain antagonist that blocks the transcriptional activity of full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 has antitumor effects against enzalutamide resistant castration-resistant prostate cancer (CRPC)[1].

EPI-7170

T63811-10mg 10mg Ask for price
Description: EPI-7170

EPI-7170

T63811-1g 1g Ask for price
Description: EPI-7170

EPI-7170

T63811-1mg 1mg Ask for price
Description: EPI-7170

EPI-7170

T63811-50mg 50mg Ask for price
Description: EPI-7170

EPI-7170

T63811-5mg 5mg Ask for price
Description: EPI-7170

EPI-001

555572 10.0mg
EUR 250

EPI-001

B6041-10 10 mg
EUR 56
Description: Endocrinology and Hormones|Androgen Receptor

EPI-001

B6041-200 200 mg
EUR 376
Description: Endocrinology and Hormones|Androgen Receptor

EPI-001

B6041-50 50 mg
EUR 168
Description: Endocrinology and Hormones|Androgen Receptor

EPI-001

MBS131396-100mg 100mg
EUR 1495

EPI-001

HY-100348 10 mg
EUR 333.34
Description: EPI-001, a selective inhibitor of Androgen Receptor (AR), targets transactivation unit 5 (Tau-5) of the AR. EPI-001 can inhibit transactivation of the AR amino-terminal domain (NTD), with an IC50 of ~6 μM. EPI-001 is also a selective modulator of PPARγ. EPI-001 is active against castration-resistant prostate cancer[1][2][3].

EPI-743

HY-16772 10 mg
EUR 1028.15
Description: EPI-743 (Vatiquinone; α-Tocotrienol quinone; PTC-743; NCT04378075) is a potent cellular oxidative stress protectant, inhibits ferroptosis in cells, which could be used for the study for mitochondrial diseases. EPI-743 is a synthetic analog of vitamin E with oral activity, targets repletion of reduced intracellular glutathione[1][2].

EPI-589

HY-125999 10 mg
EUR 432.91
Description: EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase enzyme inhibitor. EPI-589 has the potential for the treatment of amyotrophic lateral sclerosis (ALS)[1].

EPI-001

MBS384678-10mg 10mg
EUR 160

EPI-001

MBS384678-25mg 25mg
EUR 240

EPI-001

MBS384678-50mg 50mg
EUR 300

EPI-001

MBS384678-5x50mg 5x50mg
EUR 1340

EPI-589

MBS5766602-5mg 5mg
EUR 915

EPI-589

MBS5766602-5x5mg 5x5mg
EUR 3970

EPI-589

T11214-10mg 10mg Ask for price
Description: EPI-589

EPI-589

T11214-1g 1g Ask for price
Description: EPI-589

EPI-589

T11214-1mg 1mg Ask for price
Description: EPI-589

EPI-589

T11214-50mg 50mg Ask for price
Description: EPI-589

EPI-589

T11214-5mg 5mg Ask for price
Description: EPI-589

EPI-001

T6829-10mg 10mg Ask for price
Description: EPI-001

EPI-001

T6829-1g 1g Ask for price
Description: EPI-001

EPI-001

T6829-1mg 1mg Ask for price
Description: EPI-001

EPI-001

T6829-50mg 50mg Ask for price
Description: EPI-001

EPI-001

T6829-5mg 5mg Ask for price
Description: EPI-001

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Biotin)

MBS6333598-02mL 0.2mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Biotin)

MBS6333598-5x02mL 5x0.2mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Azide free) (HRP)

MBS6333600-02mL 0.2mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Azide free) (HRP)

MBS6333600-5x02mL 5x0.2mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 405)

MBS6333601-01mL 0.1mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 405)

MBS6333601-5x01mL 5x0.1mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 490)

MBS6333602-01mL 0.1mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 490)

MBS6333602-5x01mL 5x0.1mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 550)

MBS6333603-01mL 0.1mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 550)

MBS6333603-5x01mL 5x0.1mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 650)

MBS6333604-01mL 0.1mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 650)

MBS6333604-5x01mL 5x0.1mL
EUR 4250

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 750)

MBS6333605-01mL 0.1mL
EUR 980

PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 750)

MBS6333605-5x01mL 5x0.1mL
EUR 4250

Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag

REC32038-100 0.1
EUR 301.29
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023.

Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag

REC32038-500 0.5
EUR 1057.09
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023.

Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag

REC32039-100 0.1
EUR 301.29
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023.

Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag

REC32039-500 0.5
EUR 1057.09
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023.

EPI300 Glycerol Stock

D0357 200 μL Ask for price

EPI300 Super Competent Cells

D1035M 50x 100 μL Ask for price

EPI300 Super Competent Cells

D1035S 10x 100 μL Ask for price